Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
12/1991
12/24/1991US5075306 Thiazoloquinoxalines
12/24/1991US5075303 Pyridine derivatives
12/24/1991US5075302 Treating hypertension, congestive heart failure
12/24/1991US5075287 Enhance activity of vaccines, bactericides, antitumor agents
12/24/1991CA1293444C Amino acid chelated compositions for delivery to specific biologicaltissue sites
12/23/1991WO1992000276A2 Angiotensis converting enzyme inhibitors
12/23/1991WO1992000070A1 Piperidyl-substituted indoles
12/23/1991CA2085993A1 Angiotensin converting enzyme inhibitors
12/22/1991WO1991019717A1 Polycyclic guanine derivatives
12/22/1991CA2045095A1 Heterocyclene derivatives
12/22/1991CA2044219A1 Bicyclic heterocyclic compounds
12/21/1991CA2058920A1 17.beta.-n-monosubstituted adamantyl/carbamoyl-4-aza-5.alpha.-androst-1-en-3-ones and androstan-3-ones as 5.alpha.-reductase
12/21/1991CA2044922A1 17.beta.-hydroxybenzoyl-4-aza-5.alpha.-androst-1-en-3-ones as testoste rone reductase inhibitors
12/21/1991CA2044921A1 Specific 17 .beta.-thiobenzoyl-4-aza-5 .alpha.-androst-1-en-3-ones as antiandrogenic agents
12/21/1991CA2044914A1 17.beta.-aminobenzoyl-4-5 .alpha.-androst-1-en-3-ones as benign prostatic hypertrophy agents
12/21/1991CA2044906A1 Beta-lactams as antihypercholesterolemics
12/21/1991CA2044905A1 Selected 17 .beta.-polyaroyl-4-aza-5 .alpha.-androst-1-en-3-ones as steroidal reductase inhibitors
12/20/1991WO1991019480A1 Pharmaceutical preparation
12/20/1991CA2085100A1 Pharmaceutical preparation
12/19/1991CA2044828A1 Inhibitors of hiv reverse transcriptase
12/18/1991EP0461548A2 Method for preventing a second heart attack employing and HMG CoA reductase inhibitor
12/18/1991EP0461353A1 Biogenic amine uptake inhibitors
12/18/1991EP0461223A1 Novel 1-triacontanol derivatives
12/18/1991EP0108128B1 (met-1,des-cys1,des-tyr2,des-cys3) human gamma interferon and a dna sequence encoding it
12/18/1991CN1057003A Medicinal feed for systemic treatment of ectoparasitic and ectobacterial diseases of fish
12/17/1991US5073641 Prodrug derivatives of carboxylic acid drugs
12/17/1991US5073574 Tetrazolyl substituted benzonitriles and anti-tumor use thereof
12/17/1991US5073566 Angiotensin ii antagonist 1,3-imidazoles and use thereas
12/17/1991US5073559 2-Substituted purinone having phosphodiesterase inhibitory activity
12/17/1991US5073539 Transdermal administration of zwitterionic drugs
12/16/1991WO1991019742A1 Crystalline interleukin-4
12/16/1991CA2085377A1 Crystalline interleukin-4
12/15/1991WO1991019692A2 Calcium citrate malate composition
12/15/1991WO1991019484A1 Injectable pharmaceutical composition
12/13/1991WO1991019497A1 Inhibition of 5-lipoxygenase and cyclooxygenase pathway mediated diseases
12/13/1991CA2084290A1 Inhibition of 5-lipoxygenase and cyclooxygenase pathway mediated diseases
12/12/1991WO1992000287A2 Analogs of carbonic anhydrase inhibitors and their use as topical iop inhibitors
12/12/1991WO1991019732A1 STEROIDAL 3-ACETIC ACID DERIVATIVES AS 5α-REDUCTASE INHIBITORS
12/12/1991WO1991019009A1 The ciliary neurotrophic factor receptor
12/12/1991WO1991018981A2 Neurotropic growth factors comprising a homeobox peptide
12/12/1991WO1991018903A1 Pyrrolopyridazine compounds
12/12/1991WO1991018879A1 Phthalamic acids and their isomers for treating leukotriene-related diseases
12/12/1991WO1991018622A1 Wound healing
12/12/1991WO1991018621A1 The combination of growth hormone and insulin-like growth factor-i enhances growth
12/12/1991WO1991018620A1 Stimulation of bone marrow stromal and progenitor cells
12/12/1991WO1991018611A1 Diagnosis and treatment of viral hepatitis
12/12/1991WO1991018594A1 The pharmacological use of certain cystine derivatives
12/12/1991WO1991018591A1 Inhibition of viral infection
12/12/1991CA2084658A1 Analogs of carbonic anhydrase inhibitors and their use as topical iop inhibitors
12/12/1991CA2084292A1 Steroidal 3-acetic acid derivatives as 5.alpha.-reductase inhibitors
12/12/1991CA2083603A1 Diagnosis and treatment of viral hepatitis
12/12/1991CA2042526A1 Method for preventing a second heart attack employing an hmg coa reductase inhibitor
12/11/1991EP0461039A1 Benzimidazole derivatives, process and intermediates for their preparation, their use as medicaments and pharmaceutical compositions containing them
12/11/1991EP0460924A1 Dichloroaniline compound
12/11/1991EP0460848A1 Stearidonic acid and/or eicosatetraenoic acid for the treatment of inflammations
12/11/1991EP0460690A2 Use of phenolsulfophthaline derivatives for the treatment of osteoporosis
12/11/1991EP0460622A1 Pharmaceutical preparation for the systemic treatment of toy fish and domestic fish
12/11/1991EP0460488A1 Sulfur-containing heterocyclic compounds
12/11/1991EP0460189A1 Production of biologically active platelet-derived growth factor from high expression host cell systems
12/11/1991EP0460078A1 Pharmaceutically active agents that impede amyloid formation in vivo
12/11/1991EP0460062A1 Method for the synthesis of huperzine a and analogs thereof and compounds useful therein
12/11/1991CN1056880A Pyrido (2,3-f) (1,4) thiazepines and pyrido (3,2-b) (1,5) benzothiazepines
12/10/1991US5072004 Using blocking, deblocking strategy
12/10/1991US5071875 Substituted 2-amidotetralins as melatonin agonists and antagonists
12/10/1991US5071871 Pharmaceutically useful benzo(β)pyranes and pyranopyridines
12/10/1991US5071864 Aminoalkyl-substituted 2-aminothiazoles and therapeutic agents containing them
12/10/1991US5071858 Antipsychotic benzothiopyranylamines
12/10/1991US5071855 Pharmacologically active piperidinylimidazopyridine compounds
12/10/1991US5071850 Cardiovascular disorders
12/10/1991US5071847 Bis (aryl) alkene compounds of homopiperidines useful as serotonin-antagonists
12/10/1991US5071841 Sulfur-containing heterocyclic compounds useful for the treatment of osteoporosis, and their production
12/10/1991US5071838 Treatment of shock by cyclodextrins and their derivatives
12/10/1991US5071655 Pharmaceutical combination for treatment of bone-wasting diseases
12/09/1991CA2044124A1 Benzimadazol derivatives, the process for their preparation, the new intermediates obtained, their applicaiton as drugs and the pharmaceutical composition containing such
12/08/1991WO1991018897A1 Therapeutic heterocyclic compounds
12/08/1991WO1991018883A1 Amide linked pyridyle-benzoic acid derivatives for treating leukotriene-related diseases
12/08/1991WO1991018880A1 Benzoic acid derivatives for treating leukotriene-related diseases
12/08/1991WO1991018601A1 Benzoic acid derivatives
12/08/1991CA2083958A1 Benzoic acid derivatives for treating leukotriene-related disease
12/08/1991CA2083957A1 Pyridyl-benzoic acid derivatives for treating leukotriene-related diseases
12/08/1991CA2083956A1 Amide linked pyridyl-benzoic acid derivatives for treating leukotriene-related diseases
12/07/1991WO1991018889A1 Leukotriene antagonists
12/07/1991WO1991018623A1 Recombinantly produced lipases for therapeutical treatment
12/07/1991CA2084184A1 Recombinantly produced lipases for therapeutical treatment
12/07/1991CA2083610A1 Leukotriene antagonists
12/07/1991CA2043137A1 Essential fatty acid treatment
12/06/1991CA2043850A1 Dichloroaniline compound
12/04/1991EP0459748A2 Thien-2-yl methylurea derivatives as leukotriene inhibitors
12/04/1991EP0459702A1 Azole Derivatives
12/04/1991EP0459630A2 Polypeptides
12/04/1991EP0459453A2 Use of pravastatin for preventing onset of restenosis after angioplasty
12/04/1991EP0459449A1 Furano[2,3-F]isoindoles as aldose reductase inhibitors
12/04/1991EP0459381A2 Process for the preparation of 10-(2-propynyl)ester-4-ene-3,17-dione
12/04/1991EP0459318A2 Method for preventing onset of restenosis after angioplasty employing an ACE inhibitor
12/04/1991EP0459298A2 Use of substituted beta-hydroxyethylamines as potent inhibitors of a fungal exoenzyme
12/04/1991CN1056693A Pharmachutical compounds
12/04/1991CN1056690A Pyrrolopyridazine compounds
12/04/1991CN1056685A Indole derivatives and process for production thereof
12/04/1991CN1056683A Oxalylamino acid derivatives, processes for their preparation and their use as medicaments for inhibiting proline hydroxylase
12/04/1991CN1056680A Oxidant sensitive and insensitive aromatic esters as inhibitors of human neutrophil elastase
1 ... 1477 1478 1479 1480 1481 1482 1483 1484 1485 1486 1487 1488 1489 1490 1491 1492 1493 1494 1495 1496 1497 ... 1564